Mostrando ítems 1-10 de 13
Longer Life Expectancy but still Accelerating Aging in HIV Patients under Antiretroviral Therapy
(AIDS Reviews, 2018-10)
The current goal of HIV treatment is sustained undetectable plasma viremia.
Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain
(Open Forum Infectious Diseases, 2019-02)
Background. Although only 8%-10% of persons infected with human T-cell leukemia virus type 1 (HTLV-1) may develop virus-associated diseases lifelong, misdiagnosis of asymptomatic infected carriers frequently leads to late ...
HIV co-infection in HTLV-1 carriers in Spain
(Virus Research, 2019-06)
Background: Human retroviruses HIV and HTLV share transmission routes. HIV widely spread in Spain during the 80 s through injection drug use and sex, and nowadays HIV rates in Spain account for one of the largest in Europe. ...
HTLV-1 infection in solid organ transplant donors and recipients in Spain
(BMC Invectious Diseases, 2019-08-09)
Background: HTLV-1 infection is a neglected disease, despite infecting 10-15 million people worldwide and severe illnesses develop in 10% of carriers lifelong. Acknowledging a greater risk for developing HTLV-1 associated ...
Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals
(Therapeutic Advances in Infectious Disease, 2019-08)
Two kidney transplant recipients from a single donor became infected with HTLV-1 (human T-lymphotropic virus type 1) in Spain. One developed myelopathy 8 months following surgery despite early prescription of antiretroviral ...
Occult hepatitis B and HIV infection
(European Journal of Gastroenterology & Hepatology, 2019-11)
Introduction Occult hepatitis B virus (HBV) infection, so-called occult B infection (OBI), is defined by the recognition of HBV-DNA in the absence of serum hepatitis B surface antigen (HBsAg). The HBV-DNA genome in OBI is ...
Hepatitis Delta Estimates in the United States Revisited
(Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019-10-30)
To the Editor—We read with interest the article by Patel and colleagues , which reported an unexpected 33% prevalence of anti–hepatitis delta virus antibodies (anti-HDV-Abs) in a large and representative US household ...
Keeping alive enterprises while embracing unprecedented COVID-19 restrictions
(Therapeutic Advances in Infectious Disease, 2020-04)
COVID-19 is rapidly expanding globally, with more than 1,800,000 cases and 105,000 deaths to date (April 11, 2020) (www.worldometers.info). The WHO upgrade to pandemic, the emergency declaration in the United States, and ...
Main differences between the first and second waves of COVID-19 in Madrid, Spain
(International journal of infectious diseases, 2021)
Background: The emergence and rapid global spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) represents a major challenge to health services, and has disrupted social and economic activities worldwide. ...
Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Adults in Madrid, Spain
(Clinical infectious diseases, 2021)
We read with interest the article by Huff and Singh  in which they highlight the role of asymptomatic transmissions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The authors point out that “public ...